Nevertheless, it is crucial to evaluate potential side effects associated with BC therapies such as surgical oophorectomy, chemotherapy-induced ovarian failure, and anti-estrogenic hormone therapies, including aromatase inhibitors, on the maintenance of a high quality of life for cancer survivors [132,133]. This evidence concerns the gene CYP19A1 and breast cancer.